ArticleIndian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine2025
Is Sepsis an Essential Fatty Acids Deficiency State?
Article in Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Emerging Roles and Possible Therapeutic Applications of Arachidonic Acid Metabolites in Sepsis and Sepsis-Associated Organ Dysfunction.Drug design, development and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sepsis is associated with significant morbidity and mortality in critical care units, for which there is no effective therapy at present. The failure of corticosteroids and cytokine-targeted therapies suggests that an out-of-the-box approach is needed to understand their pathobiology and develop effective therapy. Essential fatty acids (EFAs) and their metabolites have both pro- and anti-inflammatory actions, regulate the production and actions of cytokines, and modulate immune response. Patients with sepsis have significantly lower concentrations of gamma-linolenic acid (GLA), dihomo-GLA (DGLA), arachidonic acid (AA) of the n-6 series, and alpha-linolenic acid (ALA) and eicosapentaenoic acid (EPA) of the n-3 series that are derived from EFAs in their plasma phospholipid fraction. Corticosteroids inhibit the metabolism of EFAs to their long-chain metabolites in addition to suppressing the formation of eicosanoids from DGLA, AA, EPA, and DHA. Interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) inhibit the activities of desaturases and thus decrease the formation of GLA and AA from LA and EPA and DHA from ALA. Thus, corticosteroids and cytokines interfere with EFA metabolism, which may explain their ineffectiveness in sepsis. It is suggested that sepsis is an EFAs deficiency state that leads to dysregulated inflammation and immune response and failure of resolution of inflammation and wound healing. It is proposed that restoring EFAs and their metabolism to normal can prevent and manage sepsis and other similar inflammatory disorders/diseases. How to cite this article: Das UN. Is Sepsis an Essential Fatty Acids Deficiency State? Indian J Crit Care Med 2025;29(10):802-806.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.